Chapter List Guidelines In a nutshellAbout these guidelinesPart A: About co-occurring conditionsPart B: Responding to co-occurring conditionsB1: Holistic health careB2: Trauma-informed careB3: Identifying co-occurring conditionsB4: Assessing riskB5: Coordinating careB6: Approaches to co-occurring conditionsB7: Managing and treating specific disordersAttention-deficit/hyperactivity disorder (ADHD)PsychosisBipolar disordersDepressionClinical presentationManaging depressive symptomsTreating depressive disordersPsychotherapyPharmacotherapyElectroconvulsive therapy (ECT)E-health interventionsPhysical activityComplementary and alternative therapiesSummaryAnxietyObsessive compulsive disorder (OCD)Trauma, post traumatic stress disorder (PTSD) and complex PTSDEating disorders (ED)Personality disordersSubstance-induced disordersOther conditionsConcluding remarksB8: Worker self-carePart C: Specific population groupsAppendicesAbbreviationsGlossaryReferencesDisclaimer and acknowledgements Download full Guidelines Order a free hard copy Electroconvulsive therapy (ECT) Download page The 2019 RANZCP clinical practice guidelines for the treatment of depression note that ECT is a highly efficacious treatment with a strong evidence base, particularly for patients with severe or psychotic depression, catatonia, high risk of suicide, or who have not responded to adequate trials of medication or psychotherapy [808]. However, only one study to date has assessed the efficacy of ECT in treating co-occurring depression and AOD use disorders [1123]. This study, a retrospective chart review comparing depressed patients with and without co-occurring AOD use disorders, found that patients with co-occurring alcohol use disorders experienced similar improvements in their depressive symptoms following ECT as those with mood disorders alone [1123]; however, patients with both co-occurring alcohol and drug use disorders experienced smaller improvements post-ECT than those with mood disorders alone [1123]. Download section Previous Next